1399-0012/asset/olbannerleft.gif?v=1&s=a3e5314f6fe9b912f2cf08e016d3eecbc0194f78)
Massive ascites after living donor liver transplantation with a right lobe graft larger than 0.8% of the recipient’s body weight
Article first published online: 15 OCT 2009
DOI: 10.1111/j.1399-0012.2009.01117.x
© 2009 John Wiley & Sons A/S
Additional Information
How to Cite
Shirouzu, Y., Ohya, Y., Suda, H., Asonuma, K. and Inomata, Y. (2010), Massive ascites after living donor liver transplantation with a right lobe graft larger than 0.8% of the recipient’s body weight. Clinical Transplantation, 24: 520–527. doi: 10.1111/j.1399-0012.2009.01117.x
Publication History
- Issue published online: 12 AUG 2010
- Article first published online: 15 OCT 2009
- Accepted for publication 11 August 2009
- Abstract
- Article
- References
- Cited By
Keywords:
- portal hyperperfusion;
- portal hypertension;
- portal venous flow
Shirouzu Y, Ohya Y, Suda H, Asonuma K, Inomata Y. Massive ascites after living donor liver transplantation with a right lobe graft larger than 0.8% of the recipient’s body weight. Clin Transplant 2010: 24: 520–527. © 2009 John Wiley & Sons A/S.
Abstract: Background: There are only limited data on post-transplant ascites unrelated to small-sized grafts in living donor liver transplantation (LDLT).
Methods: The subjects were 59 adult patients who had received right lobe LDLT with a graft weight-to-recipient weight ratio (GRWR) > 0.8%. Patients were divided into either Group 1 (n = 14, massive ascites, defined as the production of ascitic fluid > 1000 mL/d that lasted longer than 14 d after LDLT) or Group 2 (n = 45, no development of massive ascites). Patients were followed for a median period of 3.0 yr (range, 0.5–7.5 yr).
Results: Group 1 had both higher Model for End-Stage Liver Disease score and Child-Pugh score than Group 2. Portal venous flow volume just after reperfusion was significantly greater in Group 1 than Group 2 (307.8 ± 268.8 vs. 176.2 ± 75.0 mL/min/100 g graft weight, respectively; p < 0.05). Post-transplant infectious complications including ascites infection developed more frequently within the first post-transplant month in Group 1. Massive ascites was significantly associated with early graft loss (p < 0.05).
Conclusion: Post-transplant massive ascites associated with portal over-perfusion into the graft liver can develop in patients with a GRWR over 0.8%. Recipients with post-transplant massive ascites require careful management to prevent infection.